共 101 条
[1]
Rosko A(2017)Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia Am J Hematol 92 42-49
[2]
Wang HL(2022)Relapse of acute leukemia after a second allogeneic stem-cell transplantation; Is there any hope for cure? Bone Marrow Transplant 57 336-337
[3]
de Lima M(1997)Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 15 433-444
[4]
Shimoni A(2012)Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation Blood 120 2032-2041
[5]
Collins RHJ(2014)HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation Biol Blood Marrow Transplant 20 314-318
[6]
Shpilberg O(2015)DLI after haploidentical BMT with post-transplant CY Bone Marrow Transplant 50 56-61
[7]
Drobyski WR(2016)CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia Clin Adv Hematol Oncol 14 802-808
[8]
Gökbuget N(2016)Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells J Clin Invest 126 3363-3376
[9]
Stanze D(2016)Toxicities of chimeric antigen receptor T cells: recognition and management Blood 127 3321-3330
[10]
Beck J(2016)CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date Blood 127 3312-3320